News

Upcoming Conference Call Discusses Nature's Sunshine Growth

Upcoming Conference Call Discusses Nature's Sunshine Growth

Nature's Sunshine Schedule for Conference Call

Nature's Sunshine Products, Inc. (NASDAQ: NATR) is embracing new horizons with its upcoming conference call. Scheduled for Thursday, November 6, 2025, at 5:00 p.m. Eastern time, this meeting promises to be insightful as the company unveils its financial performance for the third quarter.

Details of the Financial Discussion

The conference call will be a platform for sharing crucial financial results, covering the period ended September 30, 2025. This strategic discussion will follow a press release that will provide initial insights before the call, ensuring that participants are well-informed.

Hosts of the Conference Call

The discussion will be led by Kenneth Romanzi, the CEO, and Shane Jones, the CFO of Nature's Sunshine. Their leadership will guide the conversation and a dedicated question-and-answer segment, enhancing audience engagement and clarity.

How to Participate in the Call

To join the conference call, dial in using the toll-free number 1-800-717-1738 or the international number 1-646-307-1865. Make sure to connect 5 to 10 minutes before the scheduled start time. An operator will assist in registering your name and organization to ensure a smooth experience.

Availability of the Call

The live conference will also be accessible for replay after the call concludes. The replay will be available until November 20, providing ample opportunity for those who cannot attend live to catch up. You can access the playback using toll-free number 1-844-512-2921 or international number 1-412-317-6671, referencing Replay ID: 1134830.

About Nature's Sunshine Products

Nature's Sunshine Products (NASDAQ: NATR) is renowned for its commitment to health and wellness. The company produces a wide range of nutritional and personal care products, implementing rigorous manufacturing standards to ensure quality. With operations across more than 40 countries, Nature's Sunshine is dedicated to providing effective products that meet consumer needs.

Quality and Safety Standards

All products are manufactured in-state-of-the-art facilities, emphasizing the company's dedication to the highest standards in quality, safety, and efficacy. Through continuous innovation and dedication, Nature's Sunshine aims to set the benchmark in the industry.

Investor Relations and Communication

The Investor Relations contact for Nature's Sunshine is Gateway Group, Inc. For inquiries, you may reach out to Cody Slach at 1-949-574-3860. Email correspondence can be directed to NATR@gateway-grp.com for any detailed discussions regarding investment opportunities or company updates.

Frequently Asked Questions

What is the purpose of the conference call?

The conference call is scheduled to discuss Nature's Sunshine's financial results for Q3 and engage with investors about the company's performance and outlook.

How can I participate in the call?

Interested participants can dial the conference numbers provided, ensuring they connect a few minutes early to register.

What if I miss the live event?

A replay will be available, allowing those who cannot attend the live call to catch up on the discussion.

What is Nature's Sunshine known for?

Nature's Sunshine is recognized for manufacturing high-quality herbal and nutritional supplements in a variety of health and wellness categories.

Who can I contact for investor inquiries?

For investor-related questions, contact Gateway Group, Inc., specifically Cody Slach, for assistance and information regarding Nature's Sunshine.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading